GSK to study flu vaccine already sold to U.S.

12/9/2004 | Reuters

GlaxoSmithKline said it would begin a late-stage study of its Fluarix flu vaccine, which U.S. officials already have agreed to buy on an emergency basis to help ease the shortage of flu vaccine. GSK plans a 1,000-person trial in four U.S. locations this month and expects to submit an application to the FDA for approval of the vaccine next year. The U.S. announced earlier this week it would buy up to 4 million doses of the vaccine, produced at a plant in Germany.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA